Dr. Stuart H. Isaacson, MD

Dr. Isaacson practices at Surgical Skin Specialists of South Florida LLC in Boca Raton, Florida.

Dr. Isaacson's NPI, 1023059169, was assigned on June 9, 2006. Dr. Isaacson graduated from Feinberg School of Medicine in 1988. Dr. Isaacson holds Florida license ME0072849.

Dr. Isaacson's primary practice is Surgical Skin Specialists of South Florida LLC, at 951 NW 13th St, Boca Raton, FL 33486 in Palm Beach County. The practice phone is (561) 393-6400.

Dr. Isaacson's primary practice is Surgical Skin Specialists of South Florida LLC in Boca Raton, Florida. Dr. Isaacson is also affiliated with Boca Raton Regional Hospital. The medical group on file is CORA Physical Therapy, Spanish Springs. Dmand AI also links Dr. Isaacson to 2 more hospitals, 3 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Isaacson practices, 6 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Isaacson's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Isaacson is board certified in neurology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Isaacson's licenses on file in 2 states: Florida and New York.

Dmand AI lists essential tremor and parkinson's disease among the conditions Dr. Isaacson treats.

CMS data shows 1,556 Medicare services from Dr. Isaacson across 8 procedure codes in 2024, for 361 Medicare patients. Medicare paid $163,611 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Dr. Isaacson in 2024. The largest group is 75 to 84, with 199 patients. 75% of them have high cholesterol, and 75% have parkinson's disease. 6% are also on Medicaid. Their average risk score is 1.90, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Isaacson's median patient age at 78, with 42% women.

In 2024, Dr. Isaacson wrote 2,232 Medicare Part D claims for 282 patients. 55% of them were for generic drugs. CMS names the drug for 2,099 of them, across 27 drugs with 11 or more claims each, at $3,068,674 in total drug cost. In 2023, CMS named 2,088 claims across 26 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Isaacson for performance year 2024, reported individually. Dr. Isaacson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Isaacson as offering telehealth. CMS counts 179 procedures of skin biopsy by Dr. Isaacson, more than 83% of the clinicians it reports for that procedure.

Dmand AI links 100 papers to Dr. Isaacson, published from 2013 to 2025. 2022 was the busiest year, with 19. The most frequent topics are Parkinson Disease, Antiparkinson Agents and Levodopa. Dr. Isaacson has published most often in Clin Park Relat Disord. Dr. Isaacson's most frequent co-authors are Rajesh Pahwa, MD, Robert A. Hauser, MD and Mark Floyd Lew, MD.

Dmand AI links Dr. Isaacson to 29 clinical trials, 7 of them phase 2 studies. 6 are still active or recruiting. Conditions studied include Parkinson Disease, Parkinsonian Disorders and Constipation. ACADIA Pharmaceuticals Inc. sponsors the most, 4. Open Payments lists research payments to Dr. Isaacson that name 8 trials.

CMS Open Payments shows 4,909 general payments to Dr. Isaacson from 44 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 47% of the total. MDD US Operations, LLC paid the most, $1,108,995. It also lists 198 research payments totaling $808,908 from 2016 to 2025, naming 8 clinical trials.

Dmand AI lists 2 awards for Dr. Isaacson, most recently Regional Top Doctor in 2024.

Dr. Isaacson graduated from Feinberg School of Medicine in 1988. Dr. Isaacson is a member of MDS.

Dr. Isaacson is in network with 2 carriers, including Excellus BlueCross BlueShield and CMS Medicare. Medicare plans come from the most carriers, 2. Check the plan with the practice before a visit.